couter

BGACFBioNeutra Global Corporation

Consumer StaplesPackaged Foods & Meats
Oct 15, 2026 — Potential Equity Dilution / Debt Restructuring
Chart by TradingView

The schedule

  • Thu15Oct

    Given the -$8.2M negative equity and looming liquidity shortfall, BioNeutra faces an elevated risk of a highly dilutive capital raise or debt restructuring.

  • Fri20Nov

    Q3 2026 earnings print, assessing whether VitaFiber sales can begin to offset the structural cash drain and service the debt load.

  • Fri27Nov
  • Fri26Feb
  • Tue30Mar

    Full-year 2026 results and the critical annual going-concern assessment by the company's auditors.

  • Fri28May
  • Fri27Aug

Past

  • Fri28Aug

    BioNeutra's upcoming Q2 2026 earnings print, where investors will scrutinize the $795k cash position against ongoing operational burn.